AdhexPharma

AdhexPharma is a leading independent drug delivery company based in France, specializing in Transdermal & Topical patches and Oral Thin Films technologies. Established in 2008, the company's slogan "We deliver solutions" underscores its commitment to innovation and addressing unmet medical needs. AdhexPharma boasts a GMP manufacturing facility for the European and US market, with a noteworthy track record of 4 approved products in Europe and North America and a pipeline of 6 candidates spanning different therapeutic areas such as pain, CNS, anesthesia, smoking cessation, and HRT, encompassing 505(b)2 / NDA and ANDA. The company primarily operates in the Pharmaceutical, Logistics, and Delivery industries, underscoring the diverse range of its operations and expertise. While specific details on the headquarters and recent investment information are currently unavailable, AdhexPharma's solid portfolio of approved products and promising pipeline position it as a substantial player in the pharmaceutical and drug delivery space. As the company continues to advance its innovative solutions, it presents an enticing prospect for potential investors and strategic partnerships seeking to capitalize on the evolving landscape of drug delivery technologies.